G
Gerald W. Chodak
Researcher at Weiss Memorial Hospital
Publications - 143
Citations - 8159
Gerald W. Chodak is an academic researcher from Weiss Memorial Hospital. The author has contributed to research in topics: Prostate cancer & Prostate. The author has an hindex of 50, co-authored 143 publications receiving 7987 citations. Previous affiliations of Gerald W. Chodak include University of Chicago & University of Michigan.
Papers
More filters
Journal ArticleDOI
Results of Conservative Management of Clinically Localized Prostate Cancer
Gerald W. Chodak,Ronald A. Thisted,Glenn S. Gerber,Jan-Erik Johansson,Jan Adolfsson,George W. Jones,Geoff D. Chisholm,Boaz Moskovitz,Pinhas M. Livne,John J. Warner +9 more
TL;DR: The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
Journal ArticleDOI
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
Peg Esper,Fei Mo,Fei Mo,Fei Mo,Gerald W. Chodak,Gerald W. Chodak,Gerald W. Chodak,Michael Sinner,Michael Sinner,Michael Sinner,David Cella,David Cella,David Cella,Kenneth J. Pienta,Kenneth J. Pienta,Kenneth J. Pienta +15 more
TL;DR: Sensitivity to change in performance status and PSA score over a 2-month period suggested that some subscales of the FACT-Prostate (P) (including the PCS) are sensitive to meaningful clinical change.
Journal ArticleDOI
Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment
Mark S. Soloway,Joseph V. Briggman,Gennaro A. Carpinito,Gerald W. Chodak,Paul Church,Donald L. Lamm,Paul H. Lange,Edward M. Messing,Robert M. Pasciak,George B. Reservitz,Daniel B. Rukstalis,Michael F. Sarosdy,Walter M. Stadler,Robert P. Thiel,Cheryl L. Hayden +14 more
TL;DR: This quantitative, noninvasive assay, with high negative predictive value (86%) and sensitivity to detect malignancy (100% for invasive disease and 70% overall), may be a helpful adjunct to cytology and endoscopy for monitoring disease status after endoscopic tumor resection.
Journal ArticleDOI
Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor.
TL;DR: The monoclonal antibody could also demonstrate androgen receptor-positive cells in a human prostatic cancer and in a prostate with benign hyperplasia, demonstrating the use of antibodies in revealing cellular/subcellular distribution of androgen receptors in target tissues.
Journal ArticleDOI
Results of Radical Prostatectomy in Men With Clinically Localized Prostate Cancer: Multi-institutional Pooled Analysis
Glenn S. Gerber,Ronald A. Thisted,Peter T. Scardino,Hubert G.W. Frohmüller,Fritz H. Schroeder,David F. Paulson,Anthony W. Middleton,Daniel B. Rukstalis,Joseph A. Smith,Paul F. Schellhammer,Makoto Ohori,Gerald W. Chodak +11 more
TL;DR: These results offer the best currently available estimates of 10-year outcome of radical prostatectomy in men with clinically localized prostate cancer and may be useful in counseling patients with early malignancy.